Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 29;7(1):9707.
doi: 10.1038/s41598-017-10100-y.

The association between substance P and white matter integrity in medication-naive patients with major depressive disorder

Affiliations

The association between substance P and white matter integrity in medication-naive patients with major depressive disorder

Eunsoo Won et al. Sci Rep. .

Abstract

Substance P (SP) has been implicated in major depressive disorder (MDD), with SP antagonists being studied as potential antidepressants. Although impaired neural plasticity is considered a key mechanism in MDD pathophysiology, the association between SP and brain structural changes in depression has not been investigated. We investigated the correlations between SP levels and white matter (WM) integrity in 42 medication-naive patients with MDD and 57 healthy controls (HCs). Plasma levels of SP were determined, and diffusion tensor imaging (DTI) was performed to investigate microstructural changes in WM tracts. In patients, negative correlations between SP levels and fractional anisotropy (FA) values of the forceps minor of the corpus callosum, and positive correlations between SP levels and radial diffusivity (RD) and mean diffusivity (MD) values of the right corticospinal tract (CST) were observed, with no significant correlations in HCs. Linear regression analyses showed SP levels to significantly predict FA values of the forceps minor, and RD and MD values of the right CST in patients, but not in HCs. We consider our findings to contribute to the neurobiological evidence on the association between SP and brain structural changes in depression, which may be related with the pathophysiology and treatment of MDD.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Scatter plots of the linear regression analyses showing the effects of substance P (SP) levels on the forceps minor of the corpus callosum and right corticospinal tract (CST) in medication-naive patients with major depressive disorder (MDD) and healthy controls (HCs). (A) SP levels significantly predicted mean FA values of the forceps minor in patients with MDD but not in HCs, which indicates SP levels to have significant influence on the integrity of the forceps minor in the patient group, but not in the control group. (B) SP levels significantly predicted mean RD values of the right CST in patients with MDD but not in HCs, which indicates SP levels to have significant influence on the integrity of the right CST in the patient group but not in the control group. (C) SP levels significantly predicted mean MD values of the right CST in patients with MDD but not in HCs, which indicates SP levels to have significant influence on the integrity of the right CST in the patient group, but not in the control group.

Similar articles

Cited by

References

    1. Slattery DA, Hudson AL, Nutt DJ. Invited review: the evolution of antidepressant mechanisms. Fundam Clin Pharmacol. 2004;18:1–21. doi: 10.1111/j.1472-8206.2004.00195.x. - DOI - PubMed
    1. Massart R, Mongeau R, Lanfumey L. Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression. Philos Trans R Soc Lond B Biol Sci. 2012;367:2485–2494. doi: 10.1098/rstb.2012.0212. - DOI - PMC - PubMed
    1. Kramer MS, et al. Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. Neuropsychopharmacology. 2004;29:385–392. doi: 10.1038/sj.npp.1300260. - DOI - PubMed
    1. Kramer MS, et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science. 1998;281:1640–1645. doi: 10.1126/science.281.5383.1640. - DOI - PubMed
    1. Hafizi S, Chandra P, Cowen J. Neurokinin-1 receptor antagonists as novel antidepressants: trials and tribulations. Br J Psychiatry. 2007;191:282–284. doi: 10.1192/bjp.bp.107.037879. - DOI - PubMed

Publication types

LinkOut - more resources